Drug Profile


Alternative Names: Ovine polyclonal antibodies - MicroPharm

Latest Information Update: 06 Jun 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator MicroPharm
  • Class Immunotherapies; Polyclonal antibodies
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Clostridium infections

Most Recent Events

  • 31 Mar 2016 MicroPharm completes a phase I trial in Clostridium infections in United Kingdom (ISRCTN80902301)
  • 15 Dec 2015 Phase-I clinical trials in Clostridium infections in United Kingdom (IV)
  • 15 Dec 2015 Preclinical trials in Clostridium infections in United Kingdom (IV) prior to December 2015
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top